Journal Guide
Publishing in New England Journal of Medicine: Fit, Timeline & Submission Guide
The world's leading clinical journal: where practice-changing research gets published
Should you submit here?
Submit if will physicians change how they treat patients on Monday morning after reading your paper. Be careful if nEJM wants definitive answers.
84.5
Impact Factor
<5%
Acceptance Rate
21 days median to first decision
Time to First Decision
Readiness Scan
See whether your manuscript clears NEJM’s editorial screen.
Free 1 to 2 minute scan. Get a fit score, top issues, and the specific NEJM desk-reject patterns flagged before you submit.
Anthropic Privacy Partner. Your manuscript is never used to train any model.
What NEJM Publishes
NEJM publishes clinical research that directly changes medical practice. They want studies that every physician needs to know about, work that will be discussed at grand rounds worldwide the week it publishes. The bar isn't statistical significance; it's clinical significance.
- Large-scale clinical trials with definitive answers to treatment questions
- Studies that will immediately change clinical practice guidelines
- Research with clear implications for patient care decisions
- Public health findings of urgent importance
- Novel therapeutics with practice-changing efficacy data
Editor Insight
“NEJM exists to change clinical practice. Every paper should answer the question: 'Should I treat patients differently now?' If your study is scientifically interesting but doesn't directly affect patient care, it belongs in a specialty journal.”
What NEJM Editors Look For
Practice-changing clinical impact
Will physicians change how they treat patients on Monday morning after reading your paper? If the answer isn't clearly yes, NEJM probably isn't the right venue.
Hard clinical endpoints
Mortality, major cardiovascular events, disease-free survival. Surrogate endpoints (biomarkers, imaging findings) are less compelling unless clearly tied to outcomes that matter to patients.
Large, well-powered studies
NEJM rarely publishes underpowered pilot studies. If you have promising Phase 2 data, they want the Phase 3. Adequate sample size isn't optional.
Rigorous methodology
Randomization, blinding, intention-to-treat analysis, pre-registration. NEJM has zero tolerance for methodological shortcuts. Your trial design must be bulletproof.
Global relevance
Findings applicable across healthcare systems, not just in well-resourced settings. NEJM has an international readership and values work with broad applicability.
Independence from sponsor interests
Industry-sponsored trials must have clear independence safeguards. Data access, publication rights, and author control must be explicitly addressed.
Why Papers Get Rejected
These patterns appear repeatedly in manuscripts that don't make it past NEJM's editorial review:
Submitting pilot studies as Original Articles
NEJM wants definitive answers. A 50-patient study showing a promising trend belongs in a specialty journal. Come back when you have the full trial.
Focusing on surrogate endpoints
Showing that a drug improves a biomarker is less compelling than showing it prevents heart attacks or extends survival. NEJM prioritizes patient-centered outcomes.
Burying clinical implications
Your abstract should make the practice implications crystal clear. Physicians reading NEJM are busy; they need to know immediately what this means for their patients.
Single-center studies without validation path
Findings from one institution raise generalizability concerns. Multi-center designs or clear plans for external validation strengthen submissions.
Protocol deviations without justification
NEJM scrutinizes adherence to registered protocols. Any deviation needs clear, documented justification. Post-hoc analyses should be labeled as exploratory.
Inadequate safety reporting
thorough adverse event reporting isn't optional. Selective reporting of harms undermines credibility and raises ethical concerns.
Does your manuscript avoid these patterns?
The Free Readiness Scan reads your full manuscript against NEJM's criteria and flags the specific issues most likely to cause rejection.
Insider Tips from NEJM Authors
NEJM wants definitive answers, not promising signals
If your trial is Phase 2 with exciting results, resist the urge to submit to NEJM. Complete the Phase 3 first. NEJM is where you publish the answer, not the question.
The 'Monday morning' test is real
When evaluating your paper, editors ask: will a physician change practice after reading this? If the change is 'consider this option' rather than 'do this now,' impact is diluted.
NEJM has the fastest editorial process among top journals
They understand that clinical findings can be time-sensitive. If you have urgent results (pandemic, safety signal), communicate this clearly.
Editorials and perspectives are commissioned
You can't submit an opinion piece. These are invited by editors. Focus on Original Articles unless you've been contacted.
Pre-registration is scrutinized intensely
Your submitted paper must align with your registered protocol and outcomes. Any changes need explanation. Fishing expeditions are detected.
Patient-reported outcomes increasingly valued
Quality of life, functional status, patient experience: these complement hard endpoints. A drug that extends survival but destroys quality of life isn't a clear win.
The editorial process is thorough but efficient
Expect detailed statistical review. NEJM employs dedicated statisticians who will scrutinize your analysis plan and execution.
Negative trials can be published if well-designed
NEJM values well-conducted trials that definitively show a treatment doesn't work. These change practice too. They prevent use of ineffective therapies.
The NEJM Submission Process
Presubmission inquiry (rarely needed)
Response within 1 week if submittedNEJM prefers full submissions. Inquiries mainly useful for highly unusual study types.
Full submission
Decision within 21 daysComplete manuscript with structured abstract, trial registration, CONSORT checklist (for trials), data sharing statement.
Editorial review
~10 daysRapid triage by editors. High desk rejection rate (~80%). Focus on clinical significance and impact.
Statistical review
Concurrent with editorial reviewPapers advancing to peer review undergo preliminary statistical assessment.
Peer review
3-4 weeksClinical experts and methodologists. Emphasis on validity, clinical relevance, and practice impact.
Decision
21 days median to first decisionAccept, reject, or revise. Revision requests typically focused and achievable.
NEJM by the Numbers
| 2025 Impact Factor(2026 JCR release; 2nd in Medicine, General & Internal) | 84.5 |
| 5-Year Impact Factor | 86.6 |
| Submissions per year | ~5,000 Original Articles |
| Acceptance rate | <5% |
| Desk rejection rate | ~80% |
| Post-review acceptance | ~25% of reviewed |
| Median to first decision | 21 days |
| Weekly publication | 52 issues/year |
| Readership | 600,000+ physicians worldwide |
Before you submit
NEJM accepts a small fraction of submissions. Make your attempt count.
Start with the Free Readiness Scan. Unlock the Full Review from $39, with local pricing shown before checkout. If you need deeper submission planning, choose the Submission-Ready Dossier. The full report is calibrated to NEJM.
Article Types
Original Article
2,700 words, 4-5 tables/figuresFull reports of clinical research, typically randomized trials
Special Article
VariableImportant topics that don't fit standard research format
Brief Report
1,200 wordsConcise reports of important findings
Case Records of MGH
Case-based formatClinical problem-solving cases (by invitation)
Landmark NEJM Papers
Papers that defined fields and changed science:
- First use of ether anesthesia (1846)
- SPRINT trial: intensive vs. standard blood-pressure control (2015)
- Framingham Heart Study foundational papers (1961-)
- Imatinib (Gleevec) for chronic myeloid leukemia - Druker et al. (2001)
- Efficacy of COVID-19 vaccines (2020)
Preparing a NEJM Submission?
Get pre-submission feedback from reviewers who've published in NEJM and know exactly what editors look for.
Run Free Readiness ScanNeed expert depth? See Expert Review Options
Primary Fields
Browse by Field
Related Journal Guides
- Publishing in The Lancet
- Publishing in JAMA (Journal of the American Medical Association)
- Publishing in The BMJ (British Medical Journal)
- Publishing in Circulation
- Publishing in European Heart Journal
Latest Journal-Specific Guides
- Submission guideNEJM Submission GuideA practical NEJM submission guide for authors deciding whether the manuscript has the clinical consequence, breadth, and package quality NEJM expects.
- Journal assessmentIs NEJM a Good Journal? Fit VerdictA practical NEJM fit verdict for authors deciding whether the manuscript is decisive enough and broad enough for a flagship clinical audience.
- Desk rejectionHow to Avoid Desk Rejection at NEJMHow to avoid desk rejection at NEJM: prove broad clinical consequence, hard endpoints, and study authority strong enough for general medicine.
- Review timelineNew England Journal of Medicine Review Time: Time to First Decision and PublicationNEJM has one of the fastest turnaround times in academic medicine: most papers get a first decision within 1-3 weeks. That speed reflects a very high desk rejection rate. Here's the complete timeline.
More Guides for This Journal
- Acceptance rateNEJM Acceptance Rate 2026: What the Numbers MeanNEJM accepts 5-6% of manuscripts and desk-rejects over 90%. The numbers matter, but the more useful question is whether your paper is broad and practice-changing enough to clear the desk.
- Impact factorNEJM Impact Factor 2026: 84.5, Rank, and What It MeansNEJM's impact factor is high, but the real submission decision is fit. The number tells you the journal's tier, not whether a strong specialty paper will survive triage.
- Submission processNEJM Submission Process: Steps & TimelineA practical NEJM submission process guide covering what happens after upload, what editors screen for first, and what to fix before you submit.
- Manuscript prepHow to Write a NEJM Cover Letter (With Template)NEJM desk-rejects more than 80% of submissions, often within 7 days. The cover letter is your first and sometimes only chance to make the case for why your paper belongs there.
- Publishing guideNEJM Formatting Requirements: Complete Author GuideNEJM formatting: NEJM editors enforce practice-changing-evidence threshold in the first 5 days.
中文版本
阅读中文投稿指南 →Ready to submit to NEJM?
A desk rejection costs months. Get expert feedback before you submit, from scientists who know exactly what NEJM editors look for.
Avoid Desk Rejection
Get expert pre-submission review before you submit to NEJM. 3-7 day turnaround.
Manuscript Rejected?
Expert revision help to strengthen your manuscript and resubmit with confidence.
Reviewer Response Help
Get expert guidance crafting your response to NEJM reviewers.
Need field-expert depth? See Expert Review Options